
U.S. number of IPOs for neurology companies 2006-2021
In 2021, there were six IPOs of U.S. R&D-stage neurology companies that went public. There were also several years when no IPOs took place for neurology therapeutic companies. The record year in the given period was 2015, with 11 IPOs.